Clinical Trials Logo
  1. Home
  2. H1N1 Influenza
  3. NCT01008683

Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

H1N1 Influenza Clinical Trial

Official title:
Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation

Clinical Trial Summary

Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines.

In these patients the investigators will measure the specific antibody production.

Clinical Trial Description

Stem cell and and heart transplant patients will receive pandemic H1N1 influenza vaccination according to the clinical guidelines. Two doses will be given, in 3-week interval.

In these patients we will measure the specific antibody production. Blood sample 5 ml will be drawn before the first vaccine, before the second, and 3-4 weeks after the 2nd dose. ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01008683
Study type Observational
Source Hadassah Medical Organization
Contact Hadas Lemberg
Email lhadas@hadassah.org.il
Status Recruiting
Phase N/A
Start date November 2009
Completion date July 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT03641690 - Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
Terminated NCT00970606 - STIP: Statin Trial for Influenza Patients N/A
Completed NCT02921997 - H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses Phase 2
Completed NCT01011582 - Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza N/A
Active, not recruiting NCT01421251 - H1N1 Vaccine Safety in Manitoba, Canada N/A
Recruiting NCT04497311 - Tomographic Findings in COVID-19 and Influenza
Completed NCT04933994 - Comparison of COVID-19 and H1N1 Influenza Pneumonia
Completed NCT01002040 - Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV Phase 4
Unknown status NCT01127282 - The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A Phase 4
Terminated NCT01798602 - Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial Phase 2
Terminated NCT04810949 - Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml N/A
Completed NCT05080933 - ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS